Mycobacterial persistence requires the utilization of host cholesterol
暂无分享,去创建一个
[1] J. Mckinney,et al. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. , 2003, Science.
[2] K. Tanaka,et al. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis , 1995, Infection and immunity.
[3] H. Börnig,et al. Staining of cholesterol with the fluorescent antibiotic "filipin". , 1974, Acta histochemica.
[4] D. Russell,et al. Mycobacterium tuberculosis and the environment within the phagosome , 2007, Immunological reviews.
[5] C. Nathan,et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.
[6] B. Gicquel,et al. Persistence and Protective Efficacy of aMycobacterium tuberculosis Auxotroph Vaccine , 1999, Infection and Immunity.
[7] Bing Chen,et al. Vaccine Efficacy of a Lysine Auxotroph of Mycobacterium tuberculosis , 2003, Infection and Immunity.
[8] S. Falkow,et al. Complex pattern of Mycobacterium marinum gene expression during long-term granulomatous infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] J. Pieters,et al. Essential role for cholesterol in entry of mycobacteria into macrophages. , 2000, Science.
[10] R. Owen,et al. The degradation of cholesterol by Pseudomonas sp. NCIB 10590 under aerobic conditions. , 1983, Journal of lipid research.
[11] William R. Jacobs,et al. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice , 1999, Nature.
[12] Christopher J Petzold,et al. Lipidomics reveals control of Mycobacterium tuberculosis virulence lipids via metabolic coupling , 2007, Proceedings of the National Academy of Sciences.
[13] L. Dijkhuizen,et al. A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages , 2007, Proceedings of the National Academy of Sciences.
[14] E. Muñoz-Elías,et al. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence , 2005, Nature Medicine.
[15] J. Breslow,et al. Intracellular Cholesterol Transport , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[16] T. Weisbrod,et al. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis , 1995, Infection and immunity.
[17] K. Wang,et al. Mechanisms of steroid oxidation by microorganisms. IX. On the mechanism of ring A cleavage in the degradation of 9,10-seco steroids by microorganisms. , 1965, The Journal of biological chemistry.
[18] B. Nowicki,et al. Membrane Cholesterol: a Crucial Molecule Affecting Interactions of Microbial Pathogens with Mammalian Cells , 2005, Infection and Immunity.
[19] K. Haldar,et al. The Salmonella‐containing vacuole is a major site of intracellular cholesterol accumulation and recruits the GPI‐anchored protein CD55 , 2002, Cellular microbiology.
[20] N. Casali,et al. A phylogenomic analysis of the Actinomycetales mce operons , 2007, BMC Genomics.
[21] Y. Av‐Gay,et al. Cholesterol is accumulated by mycobacteria but its degradation is limited to non-pathogenic fast-growing mycobacteria. , 2000, Canadian journal of microbiology.
[22] T. Parish,et al. Mycobacterium tuberculosis protocols , 2001 .
[23] J. Flynn,et al. Reactivation of Latent Tuberculosis: Variations on the Cornell Murine Model , 1999, Infection and Immunity.
[24] H. Sobel,et al. THE ASSIMILATION OF CHOLESTEROL BY MYCOBACTERIUM SMEGMATIS , 1949, Journal of bacteriology.
[25] C. de Chastellier,et al. Cholesterol depletion in Mycobacterium avium‐infected macrophages overcomes the block in phagosome maturation and leads to the reversible sequestration of viable mycobacteria in phagolysosome‐derived autophagic vacuoles , 2006, Cellular microbiology.
[26] W. Jacobs,et al. Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis , 2003, Nature Immunology.
[27] James C. Sacchettini,et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase , 2000, Nature.
[28] C D Lima,et al. Metabolic Enzymes of Mycobacteria Linked to Antioxidant Defense by a Thioredoxin-Like Protein , 2002, Science.
[29] Christopher M. Sassetti,et al. Genetic requirements for mycobacterial survival during infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[30] E. Rubin,et al. Genes required for mycobacterial growth defined by high density mutagenesis , 2003, Molecular microbiology.
[31] C. Lima,et al. Mycobacterial polyketide-associated proteins are acyltransferases: proof of principle with Mycobacterium tuberculosis PapA5. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Hunter,et al. Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs. , 2007, Tuberculosis.
[33] I. Orme,et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.
[34] C. Sih. Mechanisms of steroid oxidation by microorganisms. , 1962, Biochimica et biophysica acta.
[35] P. Schlesinger,et al. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. , 1998, Journal of immunology.
[36] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.
[37] S. Fortune,et al. Characterization of mycobacterial virulence genes through genetic interaction mapping. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[38] R. Appelberg. Macrophage nutriprive antimicrobial mechanisms , 2006, Journal of leukocyte biology.
[39] C. Nathan,et al. The Proteasome of Mycobacterium tuberculosis Is Required for Resistance to Nitric Oxide , 2003, Science.
[40] Gregory A. Taylor,et al. Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47 , 2003, Science.
[41] W. Jacobs,et al. Attenuation of and Protection Induced by a Leucine Auxotroph of Mycobacterium tuberculosis , 2000, Infection and Immunity.